Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Comparator 1-Medical University of Vienna is a specific investigational mixture used as a control arm in a double-blind, randomized, crossover clinical trial (NCT01350089) conducted by the Medical University of Vienna. The study was designed to examine the effects of energy drink ingestion on perceived alcohol intoxication in healthy male volunteers. Comparator 1 consists of 46.5 g of ethanol (administered in the form of 37.5% vodka), 250 mL of carbonated water, and artificial fruit juice, resulting in a final volume of 500 mL. This mixture serves as the alcohol-only comparator to assess the baseline subjective and physiological effects of ethanol without the presence of caffeine or other energy drink components. Ethanol, the active pharmacological agent, primarily functions as a central nervous system depressant by modulating GABAergic and glutamatergic neurotransmission.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Comparator 1-Medical University of Vienna.